How to use Technologies searched

A search for a company looking for a cancer, preclinical stage, synthetic opportunity would use the selection "Biomedicine, Diagnostics" in 'Sector', 'Cancerous, neoplasmatic' in 'Disease Category', 'Drugs, Small Molecule' in 'Technology' and 'Preclinical' in 'Development Stage'.

Selection of 'Enabling Technology, Platform technology' in 'Sector' will identify all kinds of searches for technologies that can be used in more areas of life sciences than pharmaceuticals only.

Each search profile gives the name or a short description of the company behind the search, and a link allowing to contact your potential licensee.

Registered users can create non-public notifications profiles which will inform them about new Technologies Searched entries fitting their expertise as specified. In addition these profiles allow them to filter the available information more comfortably.


Merck Serono is looking for early stage opportunities in oncology, neurodegenerative diseases, fertility and endocrinology

Organization name

Merck Serono S.A.


Merck Serono combines its complementary expertise in new chemical entities (NCEs) and new biological entities (NBEs) to offer innovative prescription drugs of either origin.

Therapeutic Focus

In order to maximize the impact of our investments in R&D and increase our chances of success in discovering and developing new medical therapies, we focus our expertise on specific therapeutic areas.

In our R&D core areas of Oncology, Neurodegenerative Diseases and Rheumatology, we are exploiting synergies in disease mechanisms and biological pathways.

What we're looking for

We are particularly interested in opportunities that will support our strategic business objectives:

  • Enhance the productivity of our drug discovery activities with innovative and emerging technologies
  • Expand upon our Multiple Sclerosis franchise to enter other neurodegenerative disease areas
  • Expand our pipeline in Rheumatology with complementary product opportunities offering a broad indication potential
  • Grow our U.S. business with specialist-focused therapies
  • Expand our ongoing presence in the Japanese market
  • Expand our fast growing presence in China and other Emerging Markets

Merck Serono continues to seek opportunities to strengthen our franchises in:

  • Oncology
  • Neurodegenerative diseases
  • Fertility
  • Endocrinology

We are open to considering all opportunities to create value using innovative deal structures and creative alliances.

To view the contact information, attachments and url of this profile you have to login into your account or register a new account: Login Register

Your feedback to "Merck Serono is looking for early stage opportunities in oncology, neurodegenerative diseases, fertility and endocrinology"


latest entries

latest entries